249 related articles for article (PubMed ID: 21557225)
1. Prognostic molecular biomarkers for cutaneous malignant melanoma.
Tanaka R; Koyanagi K; Narita N; Kuo C; Hoon DS
J Surg Oncol; 2011 Sep; 104(4):438-46. PubMed ID: 21557225
[TBL] [Abstract][Full Text] [Related]
2. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.
Hilari JM; Mangas C; Xi L; Paradelo C; Ferrándiz C; Hughes SJ; Yueh C; Altomare I; Gooding WE; Godfrey TE
Ann Surg Oncol; 2009 Jan; 16(1):177-85. PubMed ID: 18982394
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.
Takeuchi H; Morton DL; Kuo C; Turner RR; Elashoff D; Elashoff R; Taback B; Fujimoto A; Hoon DS
J Clin Oncol; 2004 Jul; 22(13):2671-80. PubMed ID: 15226334
[TBL] [Abstract][Full Text] [Related]
4. Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.
Koh SS; Wei JP; Li X; Huang RR; Doan NB; Scolyer RA; Cochran AJ; Binder SW
Mod Pathol; 2012 Jun; 25(6):828-37. PubMed ID: 22411186
[TBL] [Abstract][Full Text] [Related]
5. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.
Bieligk SC; Ghossein R; Bhattacharya S; Coit DG
Ann Surg Oncol; 1999; 6(3):232-40. PubMed ID: 10340881
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
Siroy AE; Aung PP; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Milton DR; Curry JL; Ivan D; Prieto VG
Hum Pathol; 2017 Jan; 59():48-54. PubMed ID: 27666765
[TBL] [Abstract][Full Text] [Related]
7. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
[TBL] [Abstract][Full Text] [Related]
8. Pathologic staging of melanoma.
Ruiter DJ; Spatz A; van den Oord JJ; Cook MG;
Semin Oncol; 2002 Aug; 29(4):370-81. PubMed ID: 12170440
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
[TBL] [Abstract][Full Text] [Related]
10. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
[TBL] [Abstract][Full Text] [Related]
11. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
12. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
[TBL] [Abstract][Full Text] [Related]
13. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma.
Blaheta HJ; Schittek B; Breuninger H; Garbe C
Recent Results Cancer Res; 2001; 158():137-46. PubMed ID: 11092041
[TBL] [Abstract][Full Text] [Related]
14. Quantitative measurement of melanoma spread in sentinel lymph nodes and survival.
Ulmer A; Dietz K; Hodak I; Polzer B; Scheitler S; Yildiz M; Czyz Z; Lehnert P; Fehm T; Hafner C; Schanz S; Röcken M; Garbe C; Breuninger H; Fierlbeck G; Klein CA
PLoS Med; 2014 Feb; 11(2):e1001604. PubMed ID: 24558354
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node: detection of micrometastases of melanoma in a molecular study.
Denninghoff VC; Kahn AG; Falco J; Curutchet HP; Elsner B
Mol Diagn; 2004; 8(4):253-8. PubMed ID: 15887981
[TBL] [Abstract][Full Text] [Related]
16. [New TNM classification (AJCC 2009) and the pathological significance of sentinel lymph node biopsy in malignant melanoma].
Plótár V; Liszkay G; Ladányi A; Tóth E
Magy Onkol; 2013 Jun; 57(2):68-72. PubMed ID: 23795350
[TBL] [Abstract][Full Text] [Related]
17. Revisiting determinants of prognosis in cutaneous melanoma.
Weiss SA; Hanniford D; Hernando E; Osman I
Cancer; 2015 Dec; 121(23):4108-23. PubMed ID: 26308244
[TBL] [Abstract][Full Text] [Related]
18. [Mitosis in early invasive malignant melanoma. How reliable is histogenetic classification at stage pT1?].
Bösmüller H; Haitchi-Petnehazy S; Hintringer T; Mentzel T
Pathologe; 2012 Mar; 33(2):113-7. PubMed ID: 21845361
[TBL] [Abstract][Full Text] [Related]
19. Molecular staging of malignant melanoma: correlation with clinical outcome.
Shivers SC; Wang X; Li W; Joseph E; Messina J; Glass LF; DeConti R; Cruse CW; Berman C; Fenske NA; Lyman GH; Reintgen DS
JAMA; 1998 Oct; 280(16):1410-5. PubMed ID: 9801000
[TBL] [Abstract][Full Text] [Related]
20. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
